Titlebook: NanoBioMedicine; Shailendra K. Saxena,S. M. Paul Khurana Book 2020 Springer Nature Singapore Pte Ltd. 2020 Nanobiotechnology.Nanodiagnosti

只看該作者 · 發(fā)表于 2025-3-24 09:49:13

Current Advances in Nanotechnology and Medicineay since the time it was envisioned to be studied. The objectives and goal to establish global roadmaps in nanomedicine are guided by the need to take care of life-threatening clinical issues. Nanomedicine has a potential to combat several human diseases including cancer as well as infectious, neuro

只看該作者 · 發(fā)表于 2025-3-24 11:40:11

只看該作者 · 發(fā)表于 2025-3-24 17:13:15

只看該作者 · 發(fā)表于 2025-3-24 22:07:56

Modern Approaches in Nanomedicine for NeuroAIDS and CNS Drug Deliveryentration of drug to the CNS resulting in low efficacy of HAART in the CNS. Development of novel nanotechnology-based drug delivery methods for ARV drugs can increase the effectiveness of regimen with fewer side effects and better patient compliance which reduces financial load of healthcare system.

只看該作者 · 發(fā)表于 2025-3-25 02:10:34

Biomedical Applications of Viral Nanoparticles in Vaccine Therapyapsid protein?(CPs). The CPs of viruses are the protein-building blocks that can self-assemble and are inherently biodegradable. The capsids that are generated artificially using the modified version of the CPs are known as virus-like particles (VLPs) to which ligands, peptides, and other agents are

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-21 06:42
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved